Chicago Partners Discloses $5.7 Million in New Third-Quarter ETF Holdings

12 sourcesUpdated Nov 11, 20261 min read

0

Chicago Partners Discloses $5.7 Million in New Third-Quarter ETF Holdings — © IJR

Sponsored

Chicago Partners Investment Group LLC reported new third-quarter positions in five exchange-traded funds, according to regulatory filings. The purchases included 10,074 shares of the iShares S&P Mid-Cap 400 Growth ETF, 24,498 shares of Innovator U.S. Equity Power Buffer ETF – June, and 15,790 shares of Dimensional U.S. Targeted Value ETF, each valued at about $1.1 million. It also bought 45,265 shares of Innovator Equity Defined Protection ETF 1 Yr September, worth about $1.26 million, and 24,791 shares of Innovator U.S. Equity Buffer ETF – May, worth about $1.2 million.

Sponsored

In this story:

More on this story

Back to News

World

Pope Leo XIV Visits Argentina Amid Milei Tensions

Pope Leo XIV’s visit to Argentina—the first papal visit since 1987—is drawing attention to his ideological divide with President Javier Milei, whose austerity policies the Catholic Church says have harmed the poor. Leo’s first stop at a home for people with disabilities underscores the dispute: the facility says government cuts have halted supplies of medication, special food and diapers.

123 sources

Business

Total sources12

Last updatedNov 11, 2026

Does this breakdown look right?

Sponsored

Claim check

What each side asserts, disputes — or leaves out entirely.

Analyzing the coverage…

Where do you land?

Whose framing of this story rings truest to you?

Sponsored

Coverage

Sponsored

Comments

Ask Genius by OpenServe:

Free account · your comment posts right after signup

Sponsored

Anthropic IPO Valuation Could Reach $1.5 Trillion

Anthropic’s planned IPO is facing mounting uncertainty as investors reportedly push to lower its expected valuation from roughly $1.4 trillion–$1.5 trillion, with estimates ranging toward $1 trillion to $1.3 trillion amid a sell-off in AI stocks. Prediction-market odds for a near-term listing have also fallen, and reports say the company could reduce the offering or delay it.

398 sources

Sponsored

Business

Prime Medicine prices $125 million stock offering

Prime Medicine priced an offering of about 35.7 million new shares at $3.50 each, aiming to raise roughly $125 million before expenses, with underwriters able to buy additional shares. The company will receive the proceeds, but the discounted issuance dilutes existing shareholders; the funds are intended to support its costly development programs.

8 sources